Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Services
6.1 Stem Cell Banking
6.2 Cryopreservation
6.3 Stem Cell Acquisition and testing
Chapter 7 Market Segmentation by Treatment
7.1 Autologous Stem Cell Therapy
7.2 Allogeneic Stem Cell Therapy
7.3 Syngeneic Stem Cell Therapy
Chapter 8 Market Segmentation by Therapeutic Application
8.1 Diabetes
8.2 Neurological Disorders
8.3 Cardiovascular Disorders
8.4 Orthopaedic Treatments
8.5 Regenerative Medicine
Chapter 9 Market Segmentation by Geography
9.1 North America
9.1.1 Introduction
9.1.2 United States
9.1.3 Canada
9.1.4 Mexico
9.1.5 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1 Osiris Therapeutics, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2 Athersys
11.3 Neuralstem, Inc.
11.4 Cytori Therapeutics, Inc.
11.5 CellGenix
11.6 Advanced Cell Technology
11.7 Geron Corporation
11.8 Invitrogen
11.9 Novocell
11.10 Takeda Pharmaceutical Company
11.11 Cellular Engineering Technologies Inc.
11.12 Aastrom Biosciences, Inc.
11.13 Kite Pharma
11.14 CellGenix GmbH
11.15 Stemcells, Inc.
Chapter 12 Market Estimates and Forecasting
12.1 Market Estimates and Forecasting 2018-2024(USD Million)
12.1.1 Market Estimation and Forecasting by Services 2018-2024 (USD Million)
12.1.2 Market Estimates and Forecasting by Treatment 2018-2024 (USD Million)
12.1.3 Market Estimates and Forecasting by Therapeutic 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
Chapter 13 Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
